標(biāo)題: Titlebook: Biomaterials in Artificial Organs; J. P. Paul,J. D. S. Gaylor,T. Gilchrist Book 1984 Palgrave Macmillan, a division of Macmillan Publisher [打印本頁] 作者: 悲傷我 時(shí)間: 2025-3-21 18:24
書目名稱Biomaterials in Artificial Organs影響因子(影響力)
書目名稱Biomaterials in Artificial Organs影響因子(影響力)學(xué)科排名
書目名稱Biomaterials in Artificial Organs網(wǎng)絡(luò)公開度
書目名稱Biomaterials in Artificial Organs網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biomaterials in Artificial Organs被引頻次
書目名稱Biomaterials in Artificial Organs被引頻次學(xué)科排名
書目名稱Biomaterials in Artificial Organs年度引用
書目名稱Biomaterials in Artificial Organs年度引用學(xué)科排名
書目名稱Biomaterials in Artificial Organs讀者反饋
書目名稱Biomaterials in Artificial Organs讀者反饋學(xué)科排名
作者: Obedient 時(shí)間: 2025-3-22 00:12 作者: ALIBI 時(shí)間: 2025-3-22 00:57 作者: 四牛在彎曲 時(shí)間: 2025-3-22 07:56 作者: Acclaim 時(shí)間: 2025-3-22 09:17 作者: STELL 時(shí)間: 2025-3-22 16:08
Michael Gessler,Martina Fuchs,Matthias Pilzplasma separators have been employed more recently. The application of membrane separators has evolved over the past ten years, with clinical use beginning in 1977. Initial interest in membrane plasma separators developed as a means for on-line generation of particulate-free plasma, which could then作者: 空氣傳播 時(shí)間: 2025-3-22 18:10 作者: 乳汁 時(shí)間: 2025-3-22 23:00
J?ran Wrana,Javier Revilla Diez aroused and a wound-dressing sheet (King, 1968) based on this structure has reached the market place. In this paper, the preparation of a novel class of crystalline-rubbery polymers of PEO will be described and it will be shown that there are marked chemical and physical differences between materia作者: 培養(yǎng) 時(shí)間: 2025-3-23 02:08
Organic Acids And Other Metabolites In Renal Failure And Their Removal With Blood Purification Procfy this, the present investigators have analysed and quantified the serum organic acids in long-term RDT patients and compared them with those of the normal subject. Also reported here is the evaluation of the organic acid adsorptive capacity of haemoperfusion-type cellulose-microencapsulated activa作者: 幾何學(xué)家 時(shí)間: 2025-3-23 09:29 作者: plasma-cells 時(shí)間: 2025-3-23 10:43
,Discussion Following Chapters 7–11,e to find a physician on CAPD to speak about the treatment. Farrell asked Friedman if there are patients for whom only CAPD is suitable. Friedman replied that such patients may include, for example, someone at the Arctic Circle for whom home haemodialysis was not possible, a prisoner or some diabeti作者: countenance 時(shí)間: 2025-3-23 14:51 作者: Sad570 時(shí)間: 2025-3-23 18:43 作者: Kindle 時(shí)間: 2025-3-23 22:41 作者: 行為 時(shí)間: 2025-3-24 03:41 作者: 拘留 時(shí)間: 2025-3-24 09:55 作者: Agility 時(shí)間: 2025-3-24 13:51 作者: 盟軍 時(shí)間: 2025-3-24 15:32 作者: 詞匯表 時(shí)間: 2025-3-24 22:39
https://doi.org/10.1007/978-3-531-90372-9ving and the inherent simplicity of the method are important factors in this development, but there is also a wide range of studies reporting clinical improvement with CAPD as compared to haemodialysis (HD) (Oreopoulos, 1979).作者: INTER 時(shí)間: 2025-3-25 01:10 作者: 碎石頭 時(shí)間: 2025-3-25 07:22
Declining Utility Of Home Haemodialysis For Uraemia,lly confusing ‘menu’ of options (figure 1). Of these, home haemodialysis and live donor kidney transplantation have been generally regarded as optimal therapies. Home haemodialysis, despite its established advantages, however, is declining in popularity. The reasons for this deselection are many and form the substance of the present study.作者: 治愈 時(shí)間: 2025-3-25 10:03 作者: Rebate 時(shí)間: 2025-3-25 15:16 作者: Parley 時(shí)間: 2025-3-25 18:17
Johannes Strittmatter,Markus M. B?hnerisotopes, antigens, antibodies, vaccines, hormones and adsorbents. A number of potential applications suggested earlier have now reached a stage for clinical trial or clinical application. Reviews have been published (Chang, 1972a, 1984).作者: 詩集 時(shí)間: 2025-3-25 22:49
https://doi.org/10.1007/978-3-531-90372-978) and Nolph et al. (1980), that CAPD now accounts for 22% of all dialysis patients in the United Kingdom and 12% of all dialysis patients in the United States. The worldwide average number of CAPD patients is 8% of the total dialysis population.作者: Tdd526 時(shí)間: 2025-3-26 02:30 作者: 不能仁慈 時(shí)間: 2025-3-26 08:08
Science and Technology Studies,rial alveolar gradient of oxygen (Mahajan et al., 1977; De Backer et al., 1983). Haemodialysis with membranes of different chemical composition has been demonstrated to result in varying degrees of complement activation, leucopenia and hypoxaemia (Jacob et al., 1980; Shenonda et al., 1981; Hakim and Lowrie, 1982).作者: 文件夾 時(shí)間: 2025-3-26 11:03
Clinical Experience With Capd,78) and Nolph et al. (1980), that CAPD now accounts for 22% of all dialysis patients in the United Kingdom and 12% of all dialysis patients in the United States. The worldwide average number of CAPD patients is 8% of the total dialysis population.作者: Exposition 時(shí)間: 2025-3-26 13:51
Long-Term Evaluation Of Charcoal Haemoperfusion Combined With Dialysis For Uraemic Patients,tures of the uraemic syndrome (such as peripheral neuropathy or pericarditis) (Babb et al., 1972) it might be expected that a combination of haemodialysis and haemoperfusion would produce a more effective dialysis and a greater sense of well-being.作者: Geyser 時(shí)間: 2025-3-26 19:40
Haemodynamic Manifestations Of Blood-dialyser Interactions And Their Modification In An Animal Moderial alveolar gradient of oxygen (Mahajan et al., 1977; De Backer et al., 1983). Haemodialysis with membranes of different chemical composition has been demonstrated to result in varying degrees of complement activation, leucopenia and hypoxaemia (Jacob et al., 1980; Shenonda et al., 1981; Hakim and Lowrie, 1982).作者: 昏暗 時(shí)間: 2025-3-26 21:19
The 1983 Adam Thomson Lecture The Role Of Biomaterials In The Application Of Artificial Organs,laborative fields held of easing human suffering, and in particular of prolonging active life, and secondly because I was convinced that in view of the sense of commitment of all concerned outstanding success would be achieved’.作者: Generic-Drug 時(shí)間: 2025-3-27 01:31
Principles And Practice Of Membrane Plasmapheresis, the early fifties (Adams et al., 1952). The continuous centrifuge was developed by Judson during the following decade (Millward and Hoeltge, 1982). Although the preparative (euphemistically termed ‘donor’) application was sizeable, the therapeutic use of plasmapheresis remained limited and speciali作者: 轉(zhuǎn)向 時(shí)間: 2025-3-27 06:22
Clinical Experience With Capd,mmonly in the form of continuous ambulatory peritoneal dialysis (CAPD) but also (10%–20%) in the form of continuous cycling peritoneal dialysis (CCPD). Approximately half of the patients are situated in the United States, most of the other half in Europe, and approximately 600 patients in Australia 作者: DRILL 時(shí)間: 2025-3-27 12:07
Continuous Ambulatory Peritoneal Dialysis: A Discussion Of Some Problems,out 10% of the total dialysis population in Australia, Europe and The United States were treated with CAPD (Nolph et al., 1983). The potential cost-saving and the inherent simplicity of the method are important factors in this development, but there is also a wide range of studies reporting clinical作者: 小爭(zhēng)吵 時(shí)間: 2025-3-27 15:30 作者: debacle 時(shí)間: 2025-3-27 21:02
,Discussion Following Chapters 2–5,sease to be treated. He believed that there was a list of 55 diseases for which plasmapheresis had been tried with probably not more than one at best for which it had any value. Gurland disagreed by stating that the list of diseases was over 100 and referred to a Panel Discussion at the 1983 ASAIO m作者: Apogee 時(shí)間: 2025-3-28 01:50
Declining Utility Of Home Haemodialysis For Uraemia,e world whose kidneys have failed. Whereas in 1960 the only available treatment for renal failure was institutionally based maintenance haemodialysis (except for those rare patients with a monozygotic twin willing to serve as a kidney donor), in 1983, patient and physician may select from a potentia作者: meritorious 時(shí)間: 2025-3-28 03:46
Feedback Monitoring For Sodium And Water Transfer During Haemodialysis,0–145 mEq of Na/1 is also transported. This tremendous negative sodium transfer must be immediately compensated. This is accomplished by a shift of Na coming by diffusion from dialysate at a rate which depends upon the gradient concentration between the dialysate and plasma.作者: Spinal-Fusion 時(shí)間: 2025-3-28 10:12 作者: olfction 時(shí)間: 2025-3-28 11:39 作者: 生命 時(shí)間: 2025-3-28 15:48 作者: 剛毅 時(shí)間: 2025-3-28 19:15 作者: 天真 時(shí)間: 2025-3-29 01:43
Workshop Discussion On Chapter 13,e membrane to saline or to blood from which the white cells or platelets had been removed. He was interested in more information on the mechanism. Lindsay replied that saline had been used but that the other approaches had not been carried out. He added that an interesting feature was the fact that 作者: expository 時(shí)間: 2025-3-29 04:13 作者: Mangle 時(shí)間: 2025-3-29 08:16
New Technologies For Extracorporeal Enzymatic Detoxification, Different approaches towards this aim have been reported (Chang, 1969; Brunner and Jaworek, 1976; Schmer et al., 1981). The physiological detoxification of the majority of endogenous toxins requires phase I and phase II reactions and high energetic cofactors like uridine disphosphoglucuronic acid (作者: 突襲 時(shí)間: 2025-3-29 15:05
Biocompatibility Of Membrane Plasma Separators And Applications For Chronic Hepatic Assist,ells to complex devices utilising multiple components in an attempt to assist or replace hepatic function. Of the functions provided by the liver, detoxification has been the one most commonly addressed in hepatic assist procedures. Various techniques have been used for detoxification including perf作者: countenance 時(shí)間: 2025-3-29 17:32
Adult Rat Hepatocyte Cultures As The Cellular Component Of An Artificial Hybrid Liver,can be regained when sufficient hepatocyte regeneration occurs or a suitable donor organ is available for transplantation. The presence of phenolic compounds, free fatty acids, ammonia and mercaptans in high concentrations in the serum of patients with hepatic coma is well established (Zieve, 1981).作者: Flatus 時(shí)間: 2025-3-29 21:22 作者: 巫婆 時(shí)間: 2025-3-30 02:01 作者: 薄膜 時(shí)間: 2025-3-30 06:08
Palgrave Macmillan, a division of Macmillan Publishers Limited 1984作者: optional 時(shí)間: 2025-3-30 09:25 作者: 有花 時(shí)間: 2025-3-30 14:48
https://doi.org/10.1007/978-3-531-90372-9 the early fifties (Adams et al., 1952). The continuous centrifuge was developed by Judson during the following decade (Millward and Hoeltge, 1982). Although the preparative (euphemistically termed ‘donor’) application was sizeable, the therapeutic use of plasmapheresis remained limited and speciali作者: 運(yùn)動(dòng)性 時(shí)間: 2025-3-30 20:20
https://doi.org/10.1007/978-3-531-90372-9mmonly in the form of continuous ambulatory peritoneal dialysis (CAPD) but also (10%–20%) in the form of continuous cycling peritoneal dialysis (CCPD). Approximately half of the patients are situated in the United States, most of the other half in Europe, and approximately 600 patients in Australia 作者: novelty 時(shí)間: 2025-3-30 21:42
https://doi.org/10.1007/978-3-531-90372-9out 10% of the total dialysis population in Australia, Europe and The United States were treated with CAPD (Nolph et al., 1983). The potential cost-saving and the inherent simplicity of the method are important factors in this development, but there is also a wide range of studies reporting clinical作者: FLIT 時(shí)間: 2025-3-31 01:48
https://doi.org/10.1007/978-3-531-90372-9 when compared with that of a healthy person. The failure of RDT to replicate the renal endocrine function or the secretory excretion function of the renal tubule cells, together with the intermittent nature (2–3 times per week) of the treatment, are considered to be among the reasons. For example, 作者: conspicuous 時(shí)間: 2025-3-31 08:54
Andreas Assum,Maximilian Hemmerlesease to be treated. He believed that there was a list of 55 diseases for which plasmapheresis had been tried with probably not more than one at best for which it had any value. Gurland disagreed by stating that the list of diseases was over 100 and referred to a Panel Discussion at the 1983 ASAIO m作者: 畏縮 時(shí)間: 2025-3-31 12:52 作者: 干涉 時(shí)間: 2025-3-31 14:48
https://doi.org/10.1007/978-3-658-20182-10–145 mEq of Na/1 is also transported. This tremendous negative sodium transfer must be immediately compensated. This is accomplished by a shift of Na coming by diffusion from dialysate at a rate which depends upon the gradient concentration between the dialysate and plasma.
